Shu Wang
China National Rice Research Institute(CN)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research
Most-Cited Works
- → Multi-task learning for segmentation and classification of tumors in 3D automated breast ultrasound images(2020)327 cited
- → Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study(2017)136 cited
- → An Essential Function of the SRC-3 Coactivator in Suppression of Cytokine mRNA Translation and Inflammatory Response(2007)131 cited
- → Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation(2008)120 cited
- → Uncertainty Aware Temporal-Ensembling Model for Semi-Supervised ABUS Mass Segmentation(2020)119 cited
- → Mice Lacking the Amplified in Breast Cancer 1/Steroid Receptor Coactivator-3 Are Resistant to Chemical Carcinogen–Induced Mammary Tumorigenesis(2005)111 cited
- → Patient-derived tumor-like cell clusters for drug testing in cancer therapy(2020)100 cited
- → Intradermal microbubbles and contrast-enhanced ultrasound (CEUS) is a feasible approach for sentinel lymph node identification in early-stage breast cancer(2015)92 cited
- → Fabrication of high drug loading levetiracetam tablets using semi-solid extrusion 3D printing(2020)88 cited
- → Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial(2022)75 cited